Ben brings venture capital and strategic investment experience from his roles at Aviva, including as founding managing director of Aviva Ventures and chairperson of Aviva Capital Partners.
Ventura Capital led the Series E round, with participation from Aviva Ventures, Horizons Ventures, and the Gates Foundation, to advance clinical trials and commercialise breath tests.
"Testament to the power of Breath Biopsy is the continued strong support we continue to enjoy from our investors. The funds closed will enable us to progress our business to the next stage, advancing clinical trials and supporting the launch and commercialization of our pipeline of unique breath tests."
Aviva Ventures led the seed financing round for the London-based healthtech firm, with participation from Ascension, Oxford Capital, and Cur8 Capital.
"So far, we’ve been driven by a singular mission to unlock and simplify access to everything you need to live a healthier life, which requires a shift in how health and well-being services are provided and paid for, and means putting the user in the driver seat and giving them more control. By creating an integrated network of health providers and payers, we can improve access to personalised health services, particularly in traditionally underfunded and underserved areas, such as early diagnosis, women’s health, mental health and neurodiversity."
National Grid Partners led the Series B round to help scale the electric vehicle software platform across Europe and North America.
"In the next few years, total EV demand in most developed countries will surpass the energy output of even the largest power plants – for example, the behemoth Palo Verde Generating Station in the US. As more EVs come online, optimised charging and load maintenance will remain critical tools for ensuring grid stability. By being able to shape and control EV load, ev.energy can both benefit the grid and help drivers to charge using the greenest and cheapest energy."
The investment round was co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures and Simplyhealth Ventures to fund US expansion and new product development.
"Our investment in Scan.com is a statement of our intent to invest in promising young digital and tech firms – they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com’s development and growth."
West Hill Capital led the Series A round with backing from Hyundai, Sumitomo, Aviva Ventures, and Breed Reply to fund international growth and product development.
"Across the world 'Smart City' projects are underway to develop autonomous vehicle and intelligent mobility solutions to help save our cities from grinding to a standstill. The challenge is real and technological innovation is racing ahead of the legacy infrastructure in place to manage a key piece of city real estate – the kerb. By empowering local authorities with the tools that help them better manage and open up their kerbside, we’re helping them to address key issues like congestion and air quality, whilst also laying the future foundations for truly sustainable intelligent mobility. It’s a real achievement for the whole team to secure this investment and I’m extremely excited to have Hyundai and Sumitomo on board to support our mission. Work is already underway to take our mission global as we aim to make the humble kerb work for everyone, and help cities thrive."